Sign in

CIK 0001785279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Metagenomi Therapeutics, Inc.

Sign in to watch
Ticker
MGX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
813909017
Phone
(510) 871-4880
Business address
5959 HORTON STREET, 7TH FLOOR, EMERYVILLE, CA, 94608
Former names
Metagenomi, Inc., Metagenomi Technologies, LLC
Open-market buys, last 90 days
$23,401
in 1 filing
Open-market sales, last 90 days
$5,107
in 3 filings

Net +$18,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-02-13 BAYER HEALTHCARE LLC 10% owner Conversion +1,770,888 1,770,888
2024-02-13 BAYER HEALTHCARE LLC 10% owner Conversion +1,180,592 2,951,480
2024-02-13 BAYER HEALTHCARE LLC 10% owner Conversion +589,662 3,541,142
2024-02-13 BAYER HEALTHCARE LLC 10% owner Conversion +509,855 4,050,997
2024-02-13 BAYER HEALTHCARE LLC 10% owner Conversion · Series A-1 Convertible Preferred Stock −3,093,580 0
2024-02-13 BAYER HEALTHCARE LLC 10% owner Conversion · Series A-4 Convertible Preferred Stock −2,062,387 0
2024-02-13 BAYER HEALTHCARE LLC 10% owner Conversion · Series B Convertible Preferred Stock −1,030,086 0
2024-02-13 BAYER HEALTHCARE LLC 10% owner Conversion · Series B-1 Convertible Preferred Stock −890,671 0
2024-02-13 Novo Holdings A/S 10% owner Conversion +839,175 939,175
2024-02-13 Novo Holdings A/S 10% owner Purchase +800,000 $15.00 $12.0M 1,739,175
2024-02-13 Novo Holdings A/S 10% owner Conversion · SERIES B PREFERRED STOCK −147,415 0
2024-02-13 Novo Holdings A/S 10% owner Conversion · SERIES B-1 PREFERRED STOCK −691,760 0
2024-02-13 Bernales Sebastian Director Conversion +513,004 769,845
2024-02-13 Bernales Sebastian Director Conversion +1,896,445 1,896,445
2024-02-13 Bernales Sebastian Director Conversion · Series A-2 Preferred Stock −353,005 0
2024-02-13 Bernales Sebastian Director Conversion · Series A-3 Preferred Stock −119,699 0
2024-02-13 Bernales Sebastian Director Conversion · Series A-4 Preferred Stock −423,469 0
2024-02-13 Bernales Sebastian Director Conversion · Series A-4 Preferred Stock −2,062,387 0
2024-02-13 Bernales Sebastian Director Conversion · Series B Preferred Stock −1,143,905 0
2024-02-13 Bernales Sebastian Director Conversion · Series B-1 Preferred Stock −106,627 0

Page 5 of 6 · 101 trades